Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik W van Delft

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Methods in Molecular Medicine|October 24, 2003
Molecular techniques to improve outcome in childhood ALLFrederik W van Delft, Vaskar Saha
Methods in Molecular Medicine|October 24, 2003
Oligonucleotide microarray analysis of gene expression in leukemiaFrederik W van Delft, Louise K Jones
Reproductive Biomedicine Online|October 17, 2019
Fertility preservation knowledge, attitudes and intentions among children by proxy and adolescents with cancerNikoletta Panagiotopoulou, Frederik W van Delft, Jane A Stewart
Haematologica|February 22, 2024
Selection of dormant cells during treatment of T-lineage lymphoblastic leukemia and CREB as a therapeutic targetDino Masic, Hayden Bell, Frederik W Van Delft, et al.
Journal of Adolescent and Young Adult Oncology|February 11, 2017
Fertility Preservation Care for Children and Adolescents with Cancer: An Inquiry to Quantify Professionals' BarriersNikoletta Panagiotopoulou, Frederik W van Delft, Juliet P Hale, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2016
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patientsVictoria J Forster, Frederik W van Delft, Susan F Baird, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2017
Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effectVictoria J Forster, Frederik W van Delft, Susan F Baird, et al.
Cancer Cell International|November 7, 2025
Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemiaHayden L Bell, Helen J Blair, Mankaran Singh, et al.
Cancer Cell International|September 15, 2023
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemiaHayden L Bell, Helen J Blair, Mankaran Singh, et al.
British Journal of Haematology|July 9, 2016
Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia - a cohort study from the United KingdomKathryn M Musgrave, Frederik W van Delft, Peter J Avery, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Methods in Molecular Medicine|October 24, 2003
Molecular techniques to improve outcome in childhood ALLFrederik W van Delft, Vaskar Saha
Methods in Molecular Medicine|October 24, 2003
Oligonucleotide microarray analysis of gene expression in leukemiaFrederik W van Delft, Louise K Jones
Reproductive Biomedicine Online|October 17, 2019
Fertility preservation knowledge, attitudes and intentions among children by proxy and adolescents with cancerNikoletta Panagiotopoulou, Frederik W van Delft, Jane A Stewart
Haematologica|February 22, 2024
Selection of dormant cells during treatment of T-lineage lymphoblastic leukemia and CREB as a therapeutic targetDino Masic, Hayden Bell, Frederik W Van Delft, et al.
Journal of Adolescent and Young Adult Oncology|February 11, 2017
Fertility Preservation Care for Children and Adolescents with Cancer: An Inquiry to Quantify Professionals' BarriersNikoletta Panagiotopoulou, Frederik W van Delft, Juliet P Hale, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2016
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patientsVictoria J Forster, Frederik W van Delft, Susan F Baird, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2017
Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effectVictoria J Forster, Frederik W van Delft, Susan F Baird, et al.
Cancer Cell International|November 7, 2025
Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemiaHayden L Bell, Helen J Blair, Mankaran Singh, et al.
Cancer Cell International|September 15, 2023
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemiaHayden L Bell, Helen J Blair, Mankaran Singh, et al.
British Journal of Haematology|July 9, 2016
Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia - a cohort study from the United KingdomKathryn M Musgrave, Frederik W van Delft, Peter J Avery, et al.
Pageof 4